Caren van Roekel

178 Chapter 6 12. Mikell JK, Mahvash A, Siman W, Mourtada F, Kappadath SC. Comparing voxel- based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for 90Y microsphere selective internal radiation therapy. EJNMMI Phys. 2015;2:16 13. Bastiaannet R, Lodge MA, de Jong H, Lam M. The unique role of fluorodeoxyglucose- PET in radioembolization. PET clinics. 2019;14(4):447-57. Epub 2019/09/02. 14. Willowson KP, Hayes AR, Chan DLH, Tapner M, Bernard EJ, Maher R, et al. Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis. EJNMMI Research. 2017;7(1):46. Epub 2017/05/26. 15. Levillain H, Duran Derijckere I, Marin G, Guiot T, Vouche M, Reynaert N, et al. (90)Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer. EJNMMI Research. 2018;8(1):60. Epub 2018/07/15. 16. Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, et al. Corrigendum: Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Physics in medicine and biology. 2008;53(22):6591-603. Epub 2008/11/04. 17. Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, et al. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Physics in medicine and biology. 2008;53(22):6591-603. Epub 2008/11/04. 18. Reinders MTM, Smits MLJ, van Roekel C, Braat AJAT. Holmium-166 Microsphere Radioembolization of Hepatic Malignancies. Semin Nucl Med. 2019;49(3):237-243. 19. Prince JF, van Rooij R, Bol GH, de Jong HWAM, van den Bosch MAAJ, Lam MGEH. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166 Ho Microspheres. J Nucl Med. 2015;56(6):817-823. 20. Braat AJAT, Prince JF, Van Rooij R, Bruijnen RCG, Van den Bosch MAAJ, Lam MGEH. Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: a cohort study. Eur Radiol. 2018;28(3):920-928. 21. Ho S, LauWY, Leung TWT, ChanM, Johnson PJ, Li AKC. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med. 1997;24(3):293-298. 22. Chiesa C, Sjogreen Gleisner K, Flux G, et al. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. Eur J Nucl Med Mol Imaging. 2017;44(11):1783-1786.